Topic

Insurance Approval

A collection of 732 issues

How to Get Soliris (Eculizumab) Covered by Aetna (CVS Health) in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Soliris Covered by Aetna (CVS Health) in Florida Step 1: Submit prior authorization through CVS Specialty Pharmacy with lab-confirmed diagnosis, meningococcal vaccination records, and REMS enrollment. Step 2: If denied, file internal appeal within 180 days using clinical documentation and medical necessity letter. Step 3: Request external
7 min read

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Blue Cross Blue Shield in Illinois: Complete Guide with Forms and Appeal Scripts

Answer Box: To get Upstaza (eladocagene exuparvovec) covered by Blue Cross Blue Shield of Illinois, you need: (1) confirmed AADC deficiency diagnosis with genetic testing, (2) prior authorization through the BCBSIL specialty drug portal, and (3) documentation from a certified gene therapy center. Start by gathering genetic test results and
5 min read

How to Get Prolastin-C Covered by UnitedHealthcare in Ohio: Appeals Guide with Forms and Timelines

Answer Box: Getting Prolastin-C Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor), with approvals typically requiring severe AAT deficiency genotype (Pi*ZZ), documented emphysema, and specific lung function criteria. If denied, you have 21 calendar days to appeal through the UnitedHealthcare Provider Portal, followed by
7 min read

How to Get Spinraza (nusinersen) Covered by Blue Cross Blue Shield of Texas: Prior Authorization, Appeals & Success Strategies

Answer Box: Getting Spinraza Covered by BCBS Texas Spinraza (nusinersen) requires prior authorization from Blue Cross Blue Shield of Texas before coverage begins. The fastest path to approval involves three key steps: 1) Have your neurologist submit comprehensive medical documentation through the Availity Portal, including genetic SMA confirmation and baseline
6 min read